Inhaler
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view illustrating the front, left side and top of my new design for an inhaler;
FIG. 2 is a perspective view similar to FIG. 1 illustrating the front, left side and top with the cover in an open position rotated from its position in FIG. 1;
FIG. 3 is a right side elevational view;
FIG. 4 is a front elevational view;
FIG. 5 is a top plan view of my device;
FIG. 6 is a left side elevational view;
FIG. 7 is a rear elevational view; and,
FIG. 8 is a bottom plan view of my new design.
Referenced Cited
Patent History
Patent number: D377215
Type: Grant
Filed: Oct 11, 1995
Date of Patent: Jan 7, 1997
Assignee: Glaxo Group Limited (London)
Inventor: Paul K. Rand (Ware)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: I. Simmons
Law Firm: Bacon & Thomas
Application Number: 0/45,153
Type: Grant
Filed: Oct 11, 1995
Date of Patent: Jan 7, 1997
Assignee: Glaxo Group Limited (London)
Inventor: Paul K. Rand (Ware)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: I. Simmons
Law Firm: Bacon & Thomas
Application Number: 0/45,153
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)